Myeloma research group

Organisational unit: Research group

Research areas and keywords

UKÄ subject classification

  • Hematology


  • myeloma, phagocyte, eosinophils, neutrophils , plasma cells, clinical trial



Our main aim is to improve outcome for the painful and fatal tumor disease, multiple myeloma (MM). To do this we pursue three lines of research; i) use investigator initiated clinical trials to test prevention strategies and ii) test new drug combinations in clinical trials and iii) investigate phagocyte subsets and functions during treatment and progression of MM.

Recent research outputs

Laura Duran-Lozano, Gudmar Thorleifsson, Aitzkoa Lopez de Lapuente Portilla, Abhishek Niroula, Molly Went, Malte Thodberg, Maroulio Pertesi, Ram Ajore, Caterina Cafaro, Pall I Olason, Lilja Stefansdottir, G Bragi Walters, Gisli H Halldorsson, Ingemar Turesson, Martin F Kaiser, Niels Weinhold, Niels Abildgaard, Niels Frost Andersen, Ulf-Henrik Mellqvist, Anders Waage & 7 others, Annette Juul-Vangsted, Unnur Thorsteinsdottir, Markus Hansson, Richard Houlston, Thorunn Rafnar, Kari Stefansson & Björn Nilsson, 2021 Apr 19, In: Blood Cancer Journal. 11, 4, 76.

Research output: Contribution to journalArticle

Hareth Nahi, Göran Walinder, Vishal Patel, Ying Qu, Aaron Levine, Istvan Majer, Lucie Kutikova, Eva Hellqvist Franck, Maria K. Svensson & Markus Hansson, 2021, In: Acta Haematologica.

Research output: Contribution to journalArticle

Jennifer L.J. Heaney, Alex Richter, Stella Bowcock, Guy Pratt, J. Anthony Child, Graham Jackson, Gareth Morgan, Ingemar Turesson & Mark T. Drayson, 2020 Apr, In: Haematologica. 105, 4, p. E169-E171

Research output: Contribution to journalLetter

View All (32)